Barinthus Biotherapeutics plc. - BRNS
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$497.5M
QoQ value delta ($000)
+$487.1M
(+4708.77%)
Implied price effect (QoQ)
+5481.86%
Shares
Total shares
7,901,825
QoQ shares delta
-1,270,349
(-13.85%)
Total shares held by funds (by quarter)
Market chart (BRNS)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| DC Funds, LP | 449,607 | 642,204 | 30.95% |
| HSG Holding Ltd | 42,216 | 1,420,473 | 2.23% |
| M&G Plc | 5,197 | 5,197,349 | 0.03% |
| RENAISSANCE TECHNOLOGIES LLC | 100 | 143,100 | 0.0% |
| Johns Hopkins University | 85 | 122,237 | 0.01% |
| CITADEL ADVISORS LLC | 83 | 118,799 | 0.0% |
| Baird Financial Group, Inc. | 74 | 105,961 | 0.0% |
| Rangeley Capital, LLC | 59 | 84,441 | 0.05% |
| HighTower Advisors, LLC | 26 | 37,450 | 0.0% |
| RHUMBLINE ADVISERS | 8 | 11,685 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 8 | 11,568 | 0.0% |
| MORGAN STANLEY | 2 | 3,406 | 0.0% |
| UBS Group AG | 2 | 3,152 | 0.0% |